Improving HPV vaccination rates through provider recommendations
Effectiveness and Mechanisms of Multilevel Implementation Strategies to Improve Provider Recommendation and Advance HPV Vaccination: a Cluster Randomized Trial
This study is testing if getting healthcare providers to recommend the HPV vaccine can help more teens get vaccinated.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 301201 (estimated) |
| Ages | 21 Years to 70 Years |
| Sex | All |
| Sponsor | Kaiser Permanente Academic / other |
| Locations | 1 site (Pasadena, California) |
| Trial ID | NCT05365048 on ClinicalTrials.gov |
What this trial studies
This study aims to enhance HPV vaccination rates among US teens by implementing a local tailoring strategy that focuses on provider recommendations. It addresses the barriers to vaccination by involving healthcare providers, including physicians, nurses, and medical assistants, in pediatric clinics. The intervention seeks to understand and improve the effectiveness of provider recommendations, which are crucial for increasing vaccine uptake. By analyzing multilevel factors influencing vaccination, the study aims to create a more comprehensive approach to overcoming existing barriers.
Who should consider this trial
Good fit: Ideal candidates for this study are parents of HPV vaccine-eligible children aged 9-12 years who visit participating pediatric clinics.
Not a fit: Patients who may not benefit from this study include those with children older than 12 years or those who do not have a clinic visit during the study period.
Why it matters
Potential benefit: If successful, this study could significantly increase HPV vaccination rates, thereby reducing the incidence of HPV-related cancers among adolescents.
How similar studies have performed: Previous studies have shown that strong provider recommendations can improve vaccination rates, but this approach aims to address the multifaceted barriers in a novel way.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All KPSC pediatric clinics. * All providers (physicians, nurses, and medical assistants) and department administrators from the pediatric department. * Parents of HPV vaccine-eligible children (9-12 years old). Exclusion Criteria: * Providers and administrators who do not work for the pediatric department * Parents of children older than 12 years and/or who did not have a clinic visit in the study period.
Where this trial is running
Pasadena, California
- Kaiser Permanente Southern California — Pasadena, California, United States (Recruiting)
Study contacts
- Principal investigator: Erin Hahn, PhD — KPSC Department of Research and Evaluation
- Study coordinator: Nancy Takahashi Cannnizzaro, PhD
- Email: Nancy.Takahashi@kp.org
- Phone: 626-564-7663
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.